Monothioglycerol

Monothioglycerol

SCHEMBL3444091

OC[C@H](O)CS

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11447458-B2 Tannic acid curing agent and preparation method and application thereof Jiangxi Science and Technology Normal University (CN) 2022-09-20 US claimed
US-20220242842-A1 TANNIC ACID CURING AGENT AND PREPARATION METHOD AND APPLICATION THEREOF Jiangxi Science and Technology Normal University (CN) 2022-08-04 US claimed
CN-110790902-B Tannin curing agent and preparation method and application thereof 江西科技师范大学 2022-04-01 CN claimed
CN-110790902-A Tannin curing agent and preparation method and application thereof 江西科技师范大学 2020-02-14 CN claimed
US-11447458-B2 Tannic acid curing agent and preparation method and application thereof Jiangxi Science and Technology Normal University (CN) 2022-09-20 US disclosed
US-20220242842-A1 TANNIC ACID CURING AGENT AND PREPARATION METHOD AND APPLICATION THEREOF Jiangxi Science and Technology Normal University (CN) 2022-08-04 US disclosed
CN-110790902-B Tannin curing agent and preparation method and application thereof 江西科技师范大学 2022-04-01 CN disclosed
CN-110790902-A Tannin curing agent and preparation method and application thereof 江西科技师范大学 2020-02-14 CN disclosed
US-20120122816-A1 COMPOSITIONS AND METHODS FOR ORGAN PRESERVATION RESOLVYX PHARMACEUTICALS, INC. (US) 2012-05-17 US disclosed
US-20120101061-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION A.T. Resolve Sarl (CH) 2012-04-26 US disclosed
US-20110190242-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE RESOLVYX PHARMACEUTICALS, INC. (US) 2011-08-04 US disclosed
US-7476676-B2 Methods for increasing bone formation using inhibitors of glycogen synthase kinase-3β ROCHE PALO ALTO LLC (US) 2009-01-13 US disclosed
EP-1307447-B1 3-INDOLYL-4-PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3BETA HOFFMANN LA ROCHE (CH) 2004-12-15 EP disclosed
US-20040214881-A1 Method for producing optically active halopropanediol derivative KANEKA CORPORATION (JP) 2004-10-28 US disclosed
EP-1251133-B1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA (JP) 2004-10-13 EP disclosed
EP-1422213-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE HALOPROPANEDIOL DERIVATIVE KANEKA CORPORATION (JP) 2004-05-26 EP disclosed
US-6680313-B2 1-HYDROXYETHYL-2(IMIDAZO(5,1B)THIAZOL-2-YL-1-CARBAPEN-2-EM-3-C CARBOXYLIC ACID OR SALT, EXCELLENT ANTIBIOTIC ACTIVITY AGAINST A WIDE SPECTRUM OF BACTERIA MEIJI SEIKA KAISHA, LTD. (JP) 2004-01-20 US disclosed
US-20030027809-A1 Novel carbapenum derivatives MEIJI SEIKA KAISHA, LTD. (JP) 2003-02-06 US disclosed
US-6479490-B2 TREATMENT OF DISEASES CHARACTERIZED BY EXCESS TH2 CYTOKINES AND/ OR AN EXCESS IGE PRODUCTION. SYNTEX (U.S.A.) LLC 2002-11-12 US disclosed
EP-1251133-A1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 2002-10-23 EP disclosed